860692P

C16:0 Ceramide (d18:2(4E,8Z)/16:0)

Avanti Research^™ - A Croda Brand 860692P, powder

• Sinónimos: N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base)
• Fórmula empírica (notación de Hill): C₃₄H₆₅NO₃
• Número de CAS: 1919028-96-8
• Peso molecular: 535.88
• UNSPSC Code: 12352211
• NACRES: NA.25

Propiedades

• form: powder
• packaging: pkg of 1 × 1 mg (860692P-1mg)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 860692P
• lipid type: sphingolipids
• shipped in: dry ice
• storage temp.: −20°C
• SMILES string: OC[C@@](NC(CCCCCCCCCCCCCCC)=O)([H])[C@]([H])(O)/C=C/CC/C=C\CCCCCCCCC
• InChI: 1S/C34H65NO3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33(37)32(31-36)35-34(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h19,21,27,29,32-33,36-37H,3-18,20,22-26,28,30-31H2,1-2H3,(H,35,38)/b21-19-,29-27+/t32-,33+/m0/s1
• InChI key: GMWIWVUTMCBDSP-JXXPSAROSA-N

Descripción

General description

C16:0 Ceramide (d18:2(4E,8Z)/16:0) or N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base) is a long chain ceramide derived from sphingosine containing two double bonds with palmitic acid. C16:0 Ceramide synthesis is catalyzed by the enzyme ceramide synthase 6 (CerS6).

Biochem/physiol Actions

C16:0-ceramide facilitates obesity-related insulin resistance. It exhibits pro-apoptotic function. Elevated levels of C16:0-ceramide has been observed in adipose tissue of obese patients.

Packaging

5 mL Amber Glass Screw Cap Vial (860692P-1mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: No data available
• flash_point_c: No data available